the curious case he curious case of of
play

The curious case he curious case of of Eos Eosinophilia - PowerPoint PPT Presentation

The curious case he curious case of of Eos Eosinophilia inophilia in in the the night night time time Tom Konikoff 6.6.17 Internal medicine D Patient background 17 y/o female Healthy No meds No


  1. The curious case he curious case of of Eos Eosinophilia inophilia in in the the night night time time Tom Konikoff 6.6.17 Internal medicine “D” ד תימינפ

  2. Patient background 17 y/o female Healthy No meds No drugs/ doesn't smoke No known allergies No relevant personal of family medical history

  3. 11/2016 Fever Productive cough Dyspnea Another hospital

  4. 11/2016 Leukocytosis 17K Eosinophilia 1900 CRP 14 (N<5) Another hospital

  5. First episode  Blood, Urine, sputum, fecal cultures - NEG  Serology for EBV , CMV , Q - FEVER - NEG  Eosinophilic pneumonia  Prednisone  Clinical improvement, fever , Eosinophil count , CXR improves  Discharge with steroid tapering down for 3 weeks

  6. But 3 weeks later….  No longer on steroids  Throat pain, dyspnea  Eosinophil count  2400  Bilateral alveolar infiltrates

  7. Prednisone 30 mg

  8. Second episode  Eos count  9000  PLT  33K  Abdominal pain + light epigastric tenderness  Maculopapular rash on limbs and abdomen

  9. Right hepatic vein ? Left hepatic vein

  10. LHV MHV RHV

  11. 12/2016 Due to susp. Budd-Chiari syn. transferred to Internal Medicine “D” Rabin Medical Center. Eosiniophilic disease with BUDD CHIARI SYNDROME

  12. in PNIMIT D  WBC 26K  INR (spont.) 1.57 ?  EOS 6.1K  PLT 13K  CRP 6  Elevated liver enzymes (AST 348, ALT 602)

  13. v

  14. Inferior Vena cava Bypass (T.I.P .S) Portal vein

  15. 1. Infectious Budd-Chiari syndrome 2. Allergies and substances secondary to 3. Idiopathic eosinophilic pneumonia 4. Vasculitis Hypereosinophilic 5. Malignancies (Solid, Hematological) syndrome 6. Hypereosinophilic syndrome

  16. Hematological Diseases & Budd-Chiari syn. Hypercoagulable state (JAK2, factor V Leiden, Erythrocytosis) • 49% of Budd-Chiari cases are due to myeloproliferative • disorders May be presenting symptom • Patients with Splanchnic vein thrombosis (including budd-chiari) • and no underlying disorder identified  JAK2 testing Smalber et al. Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis . Blood. 2012 Dec;120(25):4921-8

  17. Up to 6.3 per 100,000 HES Primary Secondary Idiopathic (neoplastic) (reactive) >80% Crane et al. Incidence of myeloproliferative hypereosinophilic sy ndrome in the United States and an estimate of all hypereosinophilic syndrome incidence. J Allergy Clin Immunol. 2010 Jul;126(1):179-81

  18. Eosinophilia & Hypercoagulability (Budd-Chiari syndrome) • Akuthota P et al. Eosinophils and disease pathogenesis. Semin Hematol. 2012 Apr; 49 (2) • Sharma SK et al . Eosinophilia: Rare cause of arterial thrombosis and cardioembolic stroke in childhood . World J Cardiol. 2012 Apr 26;4 (4):128-9  Vazques et al. Coagulation abnormalities in patients with eosinophilia . Postgrad Med J. 1987 Nov; 63

  19. Factor III (Tissue factor) Factor I (Fibrinogen) MBP , EPO thrombomodulin Platelets Akuthota P et al. Eosinophils and Disease Pathogenesis . Semin Hematol. 2012 Apr; 49 (2).

  20. But what about the treatment?

  21. DeLeve et al . Vascular disorders of the Approach to liver. Hepatology. 2009 May;49(5):1729- Is an acute well-defined 64 Budd-Chiari clot present? Yes in non-Cirrhotic No Contraindication for patients AASLD practice thrombolytic therapy? Guidelines No Yes Symptomatic? Thrombolytic therapy Yes successful? No No Yes Angiography/ stenting successful? Continue TIPS anticoagulation No Yes

  22. DeLeve et al . Vascular disorders of the Approach to liver. Hepatology. 2009 May;49(5):1729- Is an acute well-defined 64 Budd-Chiari clot present? Yes in non-Cirrhotic No Contraindication for patients AASLD practice thrombolytic therapy? Guidelines No Yes Symptomatic? Thrombolytic therapy Yes successful? No No Yes Angiography/ stenting successful? Continue TIPS anticoagulation No Yes

  23. But when is it best to TIPS? Primary intervention After Angioplasty Recurrent/ Chronic Asymptomatic BCS Cirrhosis

  24. 2016 2008 “good long - term results” Non comparison High risk Patients Primary TIPS over primary Angioplasty “better patency and less mortality with primary TIPS “ Small size, retrospective  small paper

  25. Primary Angioplasty Vs. Primary TIPS ?

  26. Whatever you choose…always treat the underlying cause!  Steroids (in our case)  Hydrea Idiopathic Hypereosinophilic Syndrome

  27. In summary  Young healthy female  Idiopathic Hypereosinophilic syndrome  Secondary Budd-Chiari  T.I.P .S (+ steroids and hydrea)  Doing well (normal LFT )

  28. Budd-Chiari syn. may be the presenting symptom of • many hematological disorders – not only Myeloproliferative Eosinophilia is a precipitating factor for • splanchnic thrombotic events Early TIPS may be considered •

  29. • ד תימינפ • ןוכמהדבכ • יגולוטמהה ןוכמ

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend